EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unlocking the power of innate lymphoid cell plasticity in the tumor microenvironment: A revolutionary pathway for cancer immunotherapy

Peng Yin, Pei Cao, Yu Liang, Chao Wang, Yu Tian

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025

DOI: 10.1016/j.bbcan.2025.189430 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025. Verfasst von Peng Yin und 4 weiteren Autor:innen. Beteiligte Einrichtung: International Genome Center, Jiangsu University, Zhenjiang 212013, China; School of Medicine, Jiangsu University, Zhenjiang 212013, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Immunity, Innate, Cell Plasticity. Die Arbeit nennt 115 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Innate lymphoid cells (ILCs) are emerging as powerful players in the immune system, capable of dramatically influencing tumor immunity. Their extraordinary plasticity, which allows them to adapt to dynamic changes in the tumor microenvironment, positions them as a double-edged sword in cancer immunotherapy. While they can drive anti-tumor immune responses, they can also promote tumor progression under certain conditions. In this review, we delve into the multifaceted roles of ILCs-focusing on ILC1, ILC2, and ILC3-and explore how their functional plasticity can be harnessed to shift their activities from immune suppression to potent anti-tumor actions. We highlight groundbreaking therapeutic strategies aimed at modulating ILC plasticity, such as metabolic reprogramming, cytokine therapy, and CAR-ILC1 therapy, each designed to enhance the anti-tumor potential of these cells. Despite the immense promise, challenges remain, including immune suppression within the TME and the short-lived efficacy of cytokines. However, targeting ILC plasticity offers a transformative approach to overcome these hurdles, presenting an opportunity to personalize cancer treatment and create tailored immunotherapies that dynamically modulate the immune response. This review underscores the game-changing potential of ILC-based therapies and provides insights into the next generation of cancer immunotherapies that could revolutionize the fight against cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNeoplasmsImmunity, InnateCell PlasticityImmunotherapyLymphocytesHumansAnimals

Stichwörter der Autor:innen

Cancer immunotherapyInnate lymphoid cells (ILCs)Metabolic reprogrammingPlasticityTumor microenvironment (TME)

Autor:innen und Institutionen

  • International Genome Center, Jiangsu University, Zhenjiang 212013, China; School of Medicine, Jiangsu University, Zhenjiang 212013, China.
  • Northern Jiangsu Cardiovascular Disease Prevention and Treatment Research Institute, Jiangsu University, Yan Cheng 224000, China; Yancheng Third People's Hospital, 224000, China; School of Life Sciences, Jiangsu Univers…
  • School of Medicine, Jiangsu University, Zhenjiang 212013, China.

Zitieren

APA

Yin, P., Cao, P., Liang, Y., Wang, C., & Tian, Y. (2025). Unlocking the power of innate lymphoid cell plasticity in the tumor microenvironment: A revolutionary pathway for cancer immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2025.189430

Vancouver

Yin P, Cao P, Liang Y, Wang C, Tian Y. Unlocking the power of innate lymphoid cell plasticity in the tumor microenvironment: A revolutionary pathway for cancer immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025. doi:10.1016/j.bbcan.2025.189430

BibTeX
@article{Yin2025,
  author = {Yin, Peng and Cao, Pei and Liang, Yu and Wang, Chao and Tian, Yu},
  title = {Unlocking the power of innate lymphoid cell plasticity in the tumor microenvironment: A revolutionary pathway for cancer immunotherapy},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2025},
  doi = {10.1016/j.bbcan.2025.189430}
}
Kostenlos starten →